ClariVest Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,871
Closed -$2.79M 688
2019
Q3
$2.79M Sell
26,871
-5,509
-17% -$592K 0.06% 216
2019
Q2
$4.16M Sell
32,380
-200
-0.6% -$27.8K 0.09% 180
2019
Q1
$4.16M Sell
32,580
-11,822
-27% -$1.5M 0.08% 211
2018
Q4
$5.55M Buy
44,402
+10,457
+31% +$1.79M 0.12% 152
2018
Q3
$7.52M Sell
33,945
-15,704
-32% -$3.18M 0.13% 121
2018
Q2
$7.95M Sell
49,649
-18,109
-27% -$2.32M 0.14% 131
2018
Q1
$6.33M Buy
67,758
+900
+1% +$67.2K 0.11% 158
2017
Q4
$4.67M Sell
66,858
-3,367
-5% -$223K 0.08% 196
2017
Q3
$4.17M Buy
70,225
+100
+0.1% +$4.98K 0.1% 195
2017
Q2
$2.91M Sell
70,125
-37
-0.1% -$1.61K 0.07% 233
2017
Q1
$3.11M Sell
70,162
-9,551
-12% -$411K 0.08% 225
2016
Q4
$3.32M Buy
79,713
+863
+1% +$34.8K 0.09% 183
2016
Q3
$2.98M Sell
78,850
-1,032
-1% -$37K 0.09% 153
2016
Q2
$2.66M Buy
79,882
+8,100
+11% +$261K 0.08% 159
2016
Q1
$2.17M Buy
+71,782
New +$2.1M 0.07% 179
2013
Q4
Sell
-72,766
Closed -$1.96M 628
2013
Q3
$1.96M Sell
72,766
-44,374
-38% -$1.19M 0.09% 161
2013
Q2
$3.02M Buy
+117,140
New +$3.08M 0.13% 148

Other funds holding MED

ClariVest Asset Management's MED Position: Q4 2019 in Review

ClariVest Asset Management sold out of Medifast (MED) in Q4 2019, closing a stake of 26,871 shares — an estimated $2.79M sold.

ClariVest Asset Management first reported a position in MED in Q2 2013 and held it in 17 quarters. The position peaked at $7.95M in Q2 2018. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • ClariVest Asset Management reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 26,871 Medifast shares in Q4 2019, an estimated $2.79M.
  • ClariVest Asset Management first reported a position in Medifast in Q2 2013 and held it in 17 quarters.
  • ClariVest Asset Management's Medifast position peaked at $7.95M in Q2 2018.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.